TORONTO--TM Bioscience, a DNA products company here, has closed a private placement with aggregate gross proceeds of $14,777,000. More than 13 million special warrants were issued and sold through an underwritten private placement by Yorkton Securities for proceeds of $10,477,000. Canadian Medical Discoveries purchased the remaining special warrants for proceeds of $4.3 million. TM Biosciences des igns, develops, and commercializes DNA products for medical diagnostics, therapeutics, biochips, functional genomics, and bioinformatics.
TM Bioscience Secures $14.8 Million Investment
Dec 18, 1998